RxDoctor Payments Data

Stevens Chancey

Family · Chattanooga, TNNPI 1437501368

Payments from drug & device makers

$956in general payments, 2019–2025

Across 59 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$293
  • Amgen$196
  • Novartis$99
  • E.r. Squibb & Sons, L.L.C.$92
  • Boston Scientific$76
  • Boehringer Ingelheim$54
  • plus $146 from 5 others

What the payments were for

  • Food & beverage$956100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$956 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$139,219
Medicare patients
878
Services billed
1,944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban204$198,472
EntrestoSacubitril/Valsartan41$42,190
XareltoRivaroxaban43$38,493
Dabigatran EtexilateDabigatran Etexilate Mesylate115$29,211
Repatha SureclickEvolocumab27$15,187
VascepaIcosapent Ethyl21$7,093
Icosapent Ethyl19$4,188
Ranolazine ErRanolazine25$3,694
Clonidine19$2,733
Metoprolol Succinate145$2,566
Flecainide Acetate47$2,156
Metoprolol Tartrate161$1,095
Nitroglycerin111$879
Atorvastatin Calcium64$813
Isosorbide Mononitrate ErIsosorbide Mononitrate70$805

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$198,472204 claims
NovartisEntresto$99$42,19041 claims
Johnson & JohnsonXarelto$293$38,49343 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,706 family providers in Tennessee.

Other family in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →